Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sarah K Friske

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
American Journal of Clinical Dermatology|February 14, 2022
New Practical Aspects of Sweet SyndromeTejas P Joshi, Sarah K Friske, David A Hsiou, et al.
Proceedings (Baylor University. Medical Center)|April 28, 2025
Influence of preoperative blood pressure on postoperative bleeding complications following Mohs micrographic surgeryRiyad N H Seervai, Sarah K Friske, Emily Powell, et al.
Cutis|July 31, 2024
Erythematous Flaky Rash on the ToeSarah K Friske, Claire J Wiggins, Alison B Carrigg, et al.
Journal of Cutaneous Pathology|September 7, 2022
The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapyRiyad N H Seervai, Sarah K Friske, Emily Y Chu, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
American Journal of Clinical Dermatology|February 14, 2022
New Practical Aspects of Sweet SyndromeTejas P Joshi, Sarah K Friske, David A Hsiou, et al.
Proceedings (Baylor University. Medical Center)|April 28, 2025
Influence of preoperative blood pressure on postoperative bleeding complications following Mohs micrographic surgeryRiyad N H Seervai, Sarah K Friske, Emily Powell, et al.
Cutis|July 31, 2024
Erythematous Flaky Rash on the ToeSarah K Friske, Claire J Wiggins, Alison B Carrigg, et al.
Journal of Cutaneous Pathology|September 7, 2022
The diverse landscape of dermatologic toxicities of non-immune checkpoint inhibitor monoclonal antibody-based cancer therapyRiyad N H Seervai, Sarah K Friske, Emily Y Chu, et al.
Pageof 1